In liver diseases, an accurate differential diagnosis between viral and autoimmune hepatitis is crucial for the choice of an appropriate therapy.
Autoimmune liver diseases include primary biliary cirrhosis (PBC), autoimmune hepatitis (AIH) and primary sclerosing cholangitis (PSC). While in AIH a chronic inflammation damages liver cells, in PBC and PSC intrahepatic small bile ducts and large bile ducts are affected.
AESKU.DIAGNOSTICS is the patent co-owner of the SLA/LP recombinant antigen, a unique and outstanding marker for AIH.